The challenges of conducting effective pharmaceutical market research in emerging markets
Published in Quirk's Marketing Research Review, April 2016, By Marc Yates, Director of Emerging Markets
Emerging markets present an exciting opportunity for growth for the pharmaceutical industry, as traditional Western markets mature and there are a limited number of new products in the pipeline offering blockbuster revenues. Some of the emerging markets, such as the BRIC nations of Brazil, Russia, India and China, are experiencing double-digit growth, as well as burgeoning public and private health care systems. A demographic of wealthy urban patients who can afford better-quality health care is on the rise, with an appetite for Western lifestyles and products.
Register to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes. Research Partnership
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space. Research Partnership
Learn about a new behavioural science-led framework incorporating AI technologies that ensures you get a true reflection of how your communications materials are consumed and processed by customers Research Partnership